Pricing Log in Create free account

Equillium, Inc. (EQ) vs Milestone Pharmaceuticals Inc. (MIST)

Equillium, Inc. and Milestone Pharmaceuticals Inc. are both Biotechnology companies. Equillium, Inc. and Milestone Pharmaceuticals Inc. are of similar size ($91.3M and $88.7M). Equillium, Inc. has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Equillium, Inc. leads on 12 and Milestone Pharmaceuticals Inc. on 3.

Valuation

Metric EQ MIST Biotechnology median
P/E n/m n/m 8.68
P/S 3.89 20.16 10.29
P/B 2.85 5.86 2.40
Price to free cash flow n/m n/m 20.52
EV/EBITDA n/m 0.06 0.68
EV/Sales 2.68 (0.87) 10.15
Earnings yield (13.99%) (89.61%) (28.86%)
Free cash flow yield (12.56%) (57.72%) (22.44%)

Profitability

Metric EQ MIST Biotechnology median
Gross margin 100.00% 13.27% 65.16%
Operating margin 0.00% (1,479.69%) 0.00%
Net margin 0.00% (1,586.01%) 0.00%
Free cash flow margin 0.00% (1,163.79%) 0.00%
Return on equity (58.98%) (35,522.62%) (56.66%)
Return on assets (50.68%) (73.36%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ MIST Biotechnology median
Revenue growth (TTM) 13.89% — 5.64%
EPS growth (last fiscal year) (69.57%) (11.94%) 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ MIST Biotechnology median
Debt to equity 0.00 3.25 0.00
Current ratio 23.40 8.13 4.72
Net debt to EBITDA 1.29 0.79 0.96

Dividend

Metric EQ MIST Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric EQ MIST Biotechnology median
Market cap 91.31m 88.66m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack